Endometriosis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Meet the diagnostic criteria for ovarian endometriosis; 2. Endometriosis staging is ASRM staging II to III; 3. Meet the diagnostic criteria for qi stagnation and blood stasis syndrome in traditional Chinese medicine; 4. Aged between 18 and 45 years with regular menstrual cycles; 5. Voluntarily signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1.Pregnant or lactating women, or those planning pregnancy within the next 6 months. 2.Individuals with known allergies or adverse reactions to the components of this medication. 3.Patients with concurrent gynecological conditions such as adenomyosis, uterine fibroids, pelvic inflammatory masses, or pelvic malignant tumors. 4.Individuals who have taken Western medicine or Chinese medicine with similar functions for the treatment of endometriosis within the past 3 months, such as dydrogesterone, gestrinone, Shao Fu Zhu Yu granules, or Gui Zhi Fu Ling capsules. 5.Patients with concurrent cardiovascular, hepatic, renal, endocrine, hematological system diseases, malignant tumors, or neurological or psychiatric disorders. 6.Individuals who refuse to sign the informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual Analog Scale (VAS);Anti-Müllerian Hormone (AMH);Sex Hormone Panel;TCM syndrome score;Recurrence rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Carbohydrate Antigen 125;Short Form McGill Pain Questionnaire;Endometriosis-specific quality of life assessment;Pregnancy rate; | — |
Countries
China
Contacts
Guangzhou University of Traditional Chinese Medicine First Affiliated Hospital